A scientific statement on the prevention and treatment of thrombosis in children with congenital heart disease has been published by Giglia et al. on behalf of the AHA. This paper adds substantially to the current literature, and yet highlights the major limitations in our current understanding and knowledge in this field.
Subscribe to Journal
Get full journal access for 1 year
only $4.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Giglia, T. M. et al. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 128, 2622–2703 (2013).
Monagle, P. et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141, e737S–e801S (2012).
National Heart, Lung, and Blood Institute. Working Group/Workshop Executive Summary. Thrombosis in Pediatric Cardiology and Adult Congenital Heart Disease [online], (2012).
Fontan, F. & Baudet, E. Surgical repair of tricuspid atresia. Thorax 26, 240–248 (1971).
Murdoch Childrens Research Institute. Fontan Registry [online], (2013).
Sistino, J. J. & Bonilha, H. S. Improvements in survival and neurodevelopmental outcomes in surgical treatment of hypoplastic left heart syndrome: a meta-analytic review. J. Extra Corpor. Technol. 44, 216–223 (2012).
Monagle, P. Anticoagulation in the young. Heart 90, 808–812 (2004).
Chan, A. K. & Monagle, P. Updates in thrombosis in pediatrics: where are we after 20 years? Hematology Am. Soc. Hematol. Educ. Program 2012, 439–443 (2012).
Andrew, M. et al. Venous thromboembolic complications (VTE) in children: first analysis of the Canadian Registry of VTE. Blood 83, 1251–1257 (1994).
Monagle, P. et al. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J. Am. Coll. Cardiol. 58, 645–651 (2011).
The author declares no competing financial interests.
About this article
Cite this article
Monagle, P. Congenital heart disease and thrombosis: what do we know?. Nat Rev Cardiol 11, 132–134 (2014). https://doi.org/10.1038/nrcardio.2013.217
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study
International Journal of Cardiology (2020)
Slow progress. How do we shift the paradigm of thinking in pediatric thrombosis and anticoagulation?
Thrombosis Research (2019)
International Journal of Cardiovascular Practice (2017)
Co-Assembly of Heparin and Polypeptide Hybrid Nanoparticles for Biomimetic Delivery and Anti-Thrombus Therapy